medigraphic.com
ISSN 0016-3813 (Impreso)

2012, Número 4

<< Anterior Siguiente >>

Gac Med Mex 2012; 148 (4)


Eritema multiforme bucal, un padecimiento a considerar en el diagnóstico diferencial de enfermedades vesiculoampollares crónicas y recurrentes. A propósito de un caso

Mancheno-Valencia A, Vega-Memije ME, Toussaint-Caire S, Martínez-Luna E, Díaz-Lozano M, Galván-Martínez I, Calderón-Pacheco G, Mosqueda-Taylor A

Idioma: Español
Referencias bibliográficas: 23
Paginas: 400-405
Archivo PDF: 662.23 Kb.


RESUMEN

Se presenta el caso de una mujer de 23 años de edad que fue referida con un cuadro de úlceras orales de aproximadamente 18 meses de evolución, diagnosticado finalmente como eritema multiforme (EM). Durante este lapso recibió múltiples diagnósticos y tratamientos, sin obtener la resolución del cuadro clínico. La paciente presentaba el antecedente de infecciones frecuentes por virus de herpes simple (VHS) en boca, y aparentemente los medicamentos recibidos contribuyeron a perpetuar los signos y síntomas de EM. La paciente presentó una rápida mejoría al suspender los medicamentos, y se prescribió un tratamiento antiviral para los episodios de infección por VHS.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol. 1983;8:763-75.

  2. Wetter DA, Davis MDP. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol. 2010;62: 45-53.

  3. Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol. 1993;128:542-5.

  4. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138(8):1019-24.

  5. Mukasa Y, Craven N. Management of toxic epidermal necrolysis and related syndromes. Postgrad Med J. 2008;84:60-5.

  6. Carducci M, Latini A, Acierno F, Amantea A, Capitanio B, Santucci B. Erythema multiforme during cytomegalovirus infection and oral therapy with terbinafine: a virus-drug interaction. J Eur Acad Dermatol Venereol. 2004;18(2):201-3.

  7. Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am. 2005 Jan;49(1):67-76, viii

  8. Farthing P, Bagan JV, Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis. 2005;11:261-7.

  9. Gonçalves LM, Bezerra Júnior JRS, Cruz MCFN. Clinical evaluation of oral lesions associated with dermatologic diseases. An Bras Dermatol. 2009;84(6):585-92.

  10. Torres MJ, Mayorga C, Blanca M. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J Investig Allergol Clin Immunol. 2009;19:80-90.

  11. Levy M. The combined effect of virus and drugs in drug-induced diseases. Med Hypotheses. 1984;14:293-6;11.

  12. Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol. 2003;3:255-60.

  13. Descamps V, Mahe E, Houhou N, et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol. 2003;148:1032-4.

  14. Pirmohamed M, Park BK. HIV and drug allergy. Curr Opin Allergy Clin Immunol. 2001;1:311-6.

  15. Martin T, Hui LI. Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis. Chin Med J. 2008;121:756-61.

  16. Crowson AN, Brown TJ, Magro CM. Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions. Am J Clin Dermatol. 2003;4:407-28.

  17. Zohdi-Mofid M, Horn TD. Acrosyringeal concentration of necrotic keratinocytes in erythema multiforme: a clue to drug etiology. Clinicopathologic review of 29 cases. J Cutan Pathol. 1997;24:235-40.

  18. Ramdial PK, Naidoo DK. Drug-induced cutaneous pathology. J Clin Pathol. 2009;62:493-504.

  19. Côté B, Wechsler J, Bastuji-Garin S, Assier H, Revuz J, Roujeau JC. Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol. 1995;131:1268-72.

  20. Kokuba H, Aurelian L, Burnett J. Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions. J Invest Dermatol. 1999;113:808-15.

  21. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol. 2003;4:561-72.

  22. Spruance SL, Wenerstrom G. Pathogenesis of recurrent herpes simplex labialis, IV: maturation of lesions within 8 hours after onset and implications for antiviral treatment. Oral Surg Oral Med Oral Pathol. 1984;58: 667-71.

  23. Spruance S, Jones T, Blatter M, et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrob Agents Chemother. 2003;47(3):1072-80.




2020     |     www.medigraphic.com